Latest Close
$24.18
Stock Hub
FHN-PH
First Horizon Corporation Depos
Assertio Therapeutics, Inc. is an American specialty pharmaceutical company. Use the sections below to move between chart, technical analysis, fundamentals, and news.
1y Change
-$0.14 (-0.59%)
Market Cap
Not available
Sector
Not available
Industry
Not available
Recommendation
Not available
52W Range
$23.84 to $25.43
Target Mean Price
Not available
Beta
Not available
Trailing P/E
Not available
Forward P/E
Not available
Price / Book
Not available
Company Overview
Assertio Therapeutics, Inc. is an American specialty pharmaceutical company. It mainly markets products for treatment in neurology, pain and diseases of the central nervous system. Depomed was founded in 1995 and is headquartered in Newark, California. It is a publicly traded company on NASDAQ, with several products approved by the United States Food and Drug Administration (FDA). On August 15, 2018, the company announced its name change from Depomed, Inc., to Assertio Therapeutics, Inc. As of 2019, Assertio markets three products approved by the FDA: Gralise, Cambia, and Zipsor.